Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

24 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Restoril Articles

US FDA calls for label changes for all sleep disorder drug products

26 March 2007

"Americans may rely too heavily on sleeping pills" when there are safer options

14 August 2006

Novartis sells off old CNS drugs in USA

25 June 2001

ICN acquires Wyeth drugs

9 December 1999

UK Industry Code of Practice Review

8 July 1996

UK To Ban Temazepam Capsules In 1996

23 October 1995

UK Ban on Temazepam Gel-Filled Capsules?

7 August 1995

Temazepam may be blacklisted

29 May 1995

CPMP RECOMMENDATIONS ON HYPNOTIC DRUGS

8 November 1993

TEMAZEPAM RECLASSIFIED IN UK?

1 February 1993

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS